These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7407315)

  • 81. Estimating health program outcomes using a Markov equilibrium analysis of disease development.
    Bush JW; Zaremba J
    Am J Public Health; 1971 Dec; 61(12):2362-75. PubMed ID: 5128607
    [No Abstract]   [Full Text] [Related]  

  • 82. A Poisson trials approach to interpopulation comparisons of cause of death data.
    Ginevan ME
    Environ Res; 1981 Jun; 25(1):147-59. PubMed ID: 7238461
    [No Abstract]   [Full Text] [Related]  

  • 83. A parametric multistate model for the analysis of carcinogenicity experiments.
    Omar RZ; Stallard N; Whitehead J
    Lifetime Data Anal; 1995; 1(4):327-46. PubMed ID: 9385108
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A comparison of continuous- and discrete- time three-state models for rodent tumorigenicity experiments.
    Lindsey JC; Ryan LM
    Environ Health Perspect; 1994 Jan; 102 Suppl 1(Suppl 1):9-17. PubMed ID: 8187731
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Nonparametric joint estimators for disease resistance and survival functions in survival/sacrifice experiments.
    Kodell RL; Shaw GW; Johnson AM
    Biometrics; 1982 Mar; 38(1):43-58. PubMed ID: 7082762
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Estimation of distributions of time to appearance of tumor and time to death from tumor after appearance in mice fed 2-acetylaminofluorene.
    Kodell RL; Farmer JH; Greenman DL; Frith CH
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):89-102. PubMed ID: 7365388
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Influence of cause-of-death assignment on time-to-tumor analyses in animal carcinogenesis studies.
    Kodell RL; Farmer JH; Gaylor DW; Cameron AM
    J Natl Cancer Inst; 1982 Sep; 69(3):659-64. PubMed ID: 7050501
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Estimation of lag time between onset of and death from an occult tumor.
    Ahn H; Moon H; Kodell RL
    J Biopharm Stat; 2008; 18(5):901-14. PubMed ID: 18781524
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Semiparametric analysis of tumor incidence rates in survival/sacrifice experiments.
    Portier CJ; Dinse GE
    Biometrics; 1987 Mar; 43(1):107-14. PubMed ID: 3567301
    [TBL] [Abstract][Full Text] [Related]  

  • 90. An illness-death model for the study of the carcinogenic process using survival/sacrifice data.
    Kodell RL; Nelson CJ
    Biometrics; 1980 Jun; 36(2):267-77. PubMed ID: 7407315
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Modeling a disease].
    Tsaregorodtsev GI; Zhirnov VD
    Vestn Akad Med Nauk SSSR; 1966; 21(1):3-9. PubMed ID: 4862610
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.